Stoke Therapeutics, Inc. (STOK)
36.41
+0.86
(+2.42%)
USD |
NASDAQ |
Feb 27, 16:00
35.85
-0.56
(-1.54%)
After-Hours: 05:49
Stoke Therapeutics Research and Development Expense (Annual) : 86.96M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Biogen, Inc. | 1.481B |
| Krystal Biotech, Inc. | 52.32M |
| Scholar Rock Holding Corp. | 182.61M |
| Zymeworks, Inc. | 134.62M |
| Moderna, Inc. | 2.917B |